Oncology is a branch of medicine that deals with tumors or cancer. It is normally concerned with diagnosis of any type of cancer occurring in a person and therapies including surgery, chemotherapy, radiotherapy and other modalities of treatment for this disease. It is also related with other factors like follow-up of patients after the successful treatment, palliative care with terminal malignancies and ethical questions surrounding the cancer care.
According to world cancer report the cancer rates can increase to about 50% that means to nearly 15 million cases by the year 2020. Therefore a tremendous amount of research is being conducted on all frontiers of oncology, ranging from cancer cell biology to chemotherapy treatment regimens and optimal palliative care to pain relief in order to develop drugs for effective prevention and cure of various types of cancers. Now-a-days one can find number of oncology CROs that offer clinical research services for the development of better oncology drugs. These CROs are the contract research organizations that offer services for oncology drug development on contract basis to offer biotechnology, pharmaceutical industries. These CRO’s often partner with oncology research companies and offer them with full plethora of Oncology research services.
Services provided by oncology research organizations often include whole range of study services ranging from initial phase I service to the final phase IV services. The early phase I studies involve the assessment of preclinical information to assess safety and tolerability of drug in humans. This includes the study about various factors like micro dosing, dose escalation, study of biomarkers, etc whereas Phase IV services include clinical plan development, project management, EDC trials, site contracting, training and monitoring. They very often include NIS trials and PMS trials. In phase 1 to 4 clinical trials the effectiveness of investigational product is surveyed in a patient population which has been selected according to strong inclusion and exclusion criteria whereas in non-interventional trials patients are treated under real life conditions to investigate the effectiveness of a drug. In post-marketing surveillance studies, the medicinal product with a market approval is prescribed in the usual manner in accordance with its approved labeling. Apart from these, oncology services also include services for clinical research data management, medical writing for oncology phases, generating statistical reports, quality assurance services for quality clinical studies without raising overhead costs and drug safety surveillance as per global regulatory standards.
# # #
Oncology CRO offers oncology services for oncology drug development and oncology research including phase I to IV study services, NIS clinical trials, PMS clinical trials, medical writing for oncology, oncology CRO data management services.